Stay updated on Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays a new revision version (v3.6.5) replacing the previous one, indicating a release update. This update pertains to the site's software layer rather than the clinical trial data or public text.
    Difference
    0.1%
    Check dated 2026-08-10T12:43:58.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows a new revision tag 'Revision: v3.6.4' replacing the previous 'Revision: v3.6.3'. This indicates a minor update to the study record page's metadata rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-07-27T06:19:18.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.2 to v3.6.3, indicating a new page build. The change does not modify study information or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the site interface.
    Difference
    0.1%
    Check dated 2026-06-28T08:44:55.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a recruitment-closed notice ('No longer looking for participants') and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a minor formatting change to the Intervention/Treatment label and an updated Revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:24:55.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a minor site update rather than a change to the study data on the page.
    Difference
    0.1%
    Check dated 2026-06-06T23:37:17.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.